RRML - Hemolysis has no influence on routine coagulation tests in subjects without anticoagulant therapy - a referral Romanian emergency hospital laboratory experience
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2016): 55%

Română English


SCImago Journal & Country Rank


Advanced search


Top 10 downloaded articles
- November 2019 -
 
Undetectable hemoglobin in a p... 6
A chronic hepatitis B patient ... 6
Exploring eponyms in a corpus ... 4
Genetic testing in pediatrics ... 4
Validation of GOD / PAP method... 3
Romanian Review of Laboratory ... 3
Hemolysis has no influence on ... 3
The influence of hemodialysis ... 3
Molecular detection of rifampi... 2
Sperm sexing technology - new ... 2

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 27(4)/2019 DOI:10.2478/rrlm-2019-0034
XML
TXT

Research article

Hemolysis has no influence on routine coagulation tests in subjects without anticoagulant therapy - a referral Romanian emergency hospital laboratory experience

Elena Binzari, Mihaela Zaharia, Stefan Barbu, Oana Roxana Oprea, Minodora Dobreanu

Correspondence should be addressed to: Mihaela Zaharia

Abstract:

The aim of this study was to determine the rate of hemolyzed specimens sent to our laboratory for coagulation testing, assess the interference of hemolysis on coagulation for patients without anticoagulant therapy and to determine the reference intervals for PT, INR and aPTT for our laboratory in order to test our own limitations. Methods: To determine the hemolysis rate, 1,689 specimens were evaluated on a visual scale and with the hemolysis icterus lipemia (HYL) test on Architect c4000 instrument. 125 blood samples collected from subjects without anticoagulant therapy were hemolyzed in vitro and the PT, INR and aPTT results were compared before and after hemolysis.To determine reference intervals (RI) for PT, INR and aPTT in our population, 125 apparently healthy human subjects (according to CLSI C28-A2) were enrolled and tests were performed on Sysmex CS 2000i, using Siemens reagents. Results: Out of 1,689 samples, 9.46% were assessed as hemolyzed by the visual scale, while HYL test showed a 6.63% hemolysis rate. We found a shortening of 0.1s for PT, a diminution with 0.01 units for INR and a prolongation with 0.9s for aPTT from in vitro hemolyzed compared to non-lyzed samples. As to the reference intervals, we obtained in our laboratory versus reagents producer: for PT 9.8-13.9 s vs 9.8-12.1 s, and for aPTT 19.1-31.5s vs 23-31.9 s respectively; 28.38% more PT results and 13.44% more aPTT results were within range when we used local laboratory RI, compared to the manufacturer’s RI. Conclusions: The rate of hemolyzed coagulation samples in our laboratory is higher than the rate found in the literature. Nevertheless, for patients without anticoagulant therapy hemolyzed samples should be processed. Using our own reference interval leads to a significant reduced number of abnormal results.

Keywords: hemolysis, coagulation, reference intervals

Received: 25.7.2019
Accepted: 10.9.2019
Published: 20.10.2019

 
  PDF Download full text PDF
(427 KB)
     
 
How to cite
Binzari E, Zaharia M, Barbu S, Oprea OR, Dobreanu M. Hemolysis has no influence on routine coagulation tests in subjects without anticoagulant therapy - a referral Romanian emergency hospital laboratory experience. Rev Romana Med Lab. 2019;27(4):375-82. DOI:10.2478/rrlm-2019-0034